Compare Mesoblast Limited (MESO) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs STMicroelectronics NV — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while STMicroelectronics NV trades at $56.02 (market cap $49.21B). The key difference: STMicroelectronics NV is far larger — about 22.3× Mesoblast Limited's market cap, and STMicroelectronics NV pays a 0.65% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | STM | |
|---|---|---|
Market Cap | $2.21B | $49.21B |
Sector | Technology | Financials |
52-Week High | $20.96 | $79.91 |
52-Week Low | $12.88 | $21.20 |
Enterprise Value | $2.21B | $47.21B |
Dividend Yield | — | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
